Your browser doesn't support javascript.
loading
Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016.
Opatowski, M; Tuppin, P; Cosker, K; Touat, M; De Lagasnerie, G; Guillemot, D; Salomon, J; Brun-Buisson, C; Watier, L.
Afiliação
  • Opatowski M; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
  • Tuppin P; Caisse nationale de l'assurance maladie, Direction de la stratégie des études et des statistiques,Paris,France.
  • Cosker K; Département Biostatistiques, Santé Publique, Information médicale, AP-HP Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix,Paris,France.
  • Touat M; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
  • De Lagasnerie G; Laboratoire Interdisciplinaire d'évaluation des Politiques Publiques,Paris,France.
  • Guillemot D; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
  • Salomon J; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
  • Brun-Buisson C; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
  • Watier L; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
Epidemiol Infect ; 147: e144, 2019 01.
Article em En | MEDLINE | ID: mdl-30869047
ABSTRACT
Massive use of antibiotics has led to increased bacterial resistance to these drugs, making infections more difficult to treat. Few studies have assessed the overall antimicrobial resistance (AMR) burden, and there is a paucity of comprehensive data to inform health policies. This study aims to assess the overall annual incident number of hospitalised patients with AMR infection in France, using the National Hospital Discharge database. All incident hospitalisations with acute infections in 2016 were extracted. Infections which could be linked with an infecting microorganism were first analysed. Then, an extrapolation of bacterial species and resistance status was performed, according to age class, gender and infection site to estimate the total number of AMR cases. Resistant bacteria caused 139 105 (95% CI 127 920-150 289) infections, resulting in a 12.3% (95% CI 11.3-13.2) resistance rate. ESBL-producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus were the most common resistant bacteria (>50%), causing respectively 49 692 (95% CI 47 223-52 142) and 19 493 (95% CI 15 237-23 747) infections. Although assumptions are needed to provide national estimates, information from PMSI is comprehensive, covering all acute bacterial infections and a wide variety of microorganisms.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bactérias / Infecções Bacterianas / Farmacorresistência Bacteriana País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bactérias / Infecções Bacterianas / Farmacorresistência Bacteriana País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França